Iconic Labs PLC Publication of a Prospectus (6382H)
March 26 2020 - 2:00AM
UK Regulatory
TIDMICON
RNS Number : 6382H
Iconic Labs PLC
26 March 2020
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM THE
UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE
REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH
RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION,
OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE
OR DISPOSE OF ANY SECURITIES IN ICONIC LABS PLC OR ANY OTHER ENTITY
IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS
DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION
WITH, ANY INVESTMENT DECISION IN RESPECT OF ICONIC LABS PLC.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF REGULATION 596/2014 ("MAR")
26(th) March 2020
Iconic Labs Plc ("Iconic Labs" or the "Company")
Publication of Prospectus And Request to lift suspension of
Shares
Iconic Labs Plc (LSE:ICON), a multi-divisional new media and
technology business, announces that the prospectus (the
"Prospectus") regarding the further issuance of up to
31,223,750,000 new ordinary shares of GBP0.00001 each in the
capital of the Company ("Ordinary Shares"), pursuant to the terms
of the Previous Financing Agreement, Deed of Issuance and the
Financing Agreement all entered into between the Company and the
European High Growth Opportunities Securitization Fund , was
yesterday approved by the Financial Conduct Authority. The
Prospectus is not, subject to certain exceptions, available
(whether through the Company's website or otherwise) to
shareholders in the United States, Australia, Canada, Japan, New
Zealand, the Republic of South Africa or any other jurisdiction in
which such release, publication or distribution would be
unlawful.
Following the publication of the Prospectus the required form 1
submissions have been made and the Company is seeking restoration
of trading of Ordinary Shares on the standard segment of the Main
Market of the London Stock Exchange. The company is hopeful this
will commence on Monday 30(th) March 2020 pending final
documentation and administrative filings.
The Prospectus has been be submitted to the National Storage
Mechanism and will be available for inspection at
http://www.morningstar.co.uk/uk/nsm following publication. It has
also been made available on the Company's website at
http://www.iconiclabs.co.uk.
All capitalised terms in this announcement have the meanings
given to them in the Prospectus, unless otherwise defined
herein.
Market Abuse Regulation (MAR) Disclosure - Certain information
contained in this announcement would have been deemed inside
information for the purposes of Article 7 of Regulation (EU) No
596/2014 until the release of this announcement.
**ENDS**
For further information, please visit the Company's website
www.iconiclabs.co.uk or contact:
Damon Heath Shard Capital Partners Tel: +44 (0) 20 7186 9950
LLP
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
PDIKKPBQDBKBANB
(END) Dow Jones Newswires
March 26, 2020 03:00 ET (07:00 GMT)
Iconic Labs (LSE:ICON)
Historical Stock Chart
From Apr 2024 to May 2024
Iconic Labs (LSE:ICON)
Historical Stock Chart
From May 2023 to May 2024